Matches in Nanopublications for { <http://bio2rdf.org/drugbank_resource:DB00526_DB01030> ?p ?o ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- drugbank_resource:DB00526_DB01030 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00526_DB01030 label "DDI between Oxaliplatin and Topotecan - Administration of Topotecan after Oxaliplatin therapy may increase the risk of hematologic toxicity, such as neutropenia and/or thrombocytopenia. A dose adjustment may be required or the sequence of administration reversed. [drugbank_resource:DB00526_DB01030]" assertion.
- drugbank_resource:DB00526_DB01030 identifier "drugbank_resource:DB00526_DB01030" assertion.
- drugbank_resource:DB00526_DB01030 title "DDI between Oxaliplatin and Topotecan - Administration of Topotecan after Oxaliplatin therapy may increase the risk of hematologic toxicity, such as neutropenia and/or thrombocytopenia. A dose adjustment may be required or the sequence of administration reversed." assertion.